Compare AU

Compare CURE vs. IHOO

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the iShares Global 100 Aud Hedged ETF (IHOO). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

IHOO

Popularity

Low

Low

Pearlers invested

80

13

Median incremental investment

$620.00

$2,000.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,296.12

$6,085.76

Average age group

> 35

> 35


Key Summary

CURE

IHOO

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

IHOO.AX was created on 2014-12-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 522.11m in AUM and 104 holdings. The fund aims to provide investors with the performance of the S&P Global 100 Hedged AUD Index, before fees and expenses. The index is designed to measure the AUD hedged performance of 100 multi-national, blue chip companies of major importance in global equity markets

Top 3 holdings

AbbVie Inc (2.62 %)

Alnylam Pharmaceuticals Inc (2.59 %)

Amgen Inc (2.59 %)

APPLE INC (11.77 %)

NVIDIA CORP (11.44 %)

MICROSOFT CORP (10.80 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Information Technology (42.76 %)

Consumer Discretionary (10.41 %)

Financials (9.81 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

United States (81.06 %)

United Kingdom of Great Britain and Northern Ireland (4.32 %)

Switzerland (3.26 %)

Management fee

0.45 %

0.43 %


Key Summary

CURE

IHOO

Issuer

Global X

iShares

Tracking index

S&P Biotechnology Select Industry

S&P Global 100 Hedged to AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0.43 %

Price

$48.91

$190.18

Size

$36.111 million

$522.345 million

10Y return

N/A

96.04 %

Annual distribution yield (5Y)

4.24 %

5.07 %

Market

ASX

ASX

First listed date

12/11/2018

18/12/2014

Purchase fee

$6.50

$6.50


Community Stats

CURE

IHOO

Popularity

Low

Low

Pearlers invested

80

13

Median incremental investment

$620.00

$2,000.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,296.12

$6,085.76

Average age group

> 35

> 35


Pros and Cons

CURE

IHOO

Pros

  • Higher exposure to US market

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

CURE

IHOO

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home